Indonesia Drug Makers Seek Restrictions On India Pharma Investors
This article was originally published in PharmAsia News
Executive Summary
Local and foreign drug makers in Indonesia are urging the government to bar new entrants, particularly Indian generics makers, from producing drugs already available in the country.